Stock Chart

LYRA

$0.50 -62.50%
Score: 43.8 HOLD
Pro
Screener
Vol: 18.07x (vs SPY: 17.9x | vs QQQ: 17.5x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Mar 16, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About LYRA - Lyra Therapeutics, Inc. Common Stock

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to …

Key Statistics

Market Cap $2M

This LYRA stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track LYRA's price movements with trendlines, gamma walls, and key support/resistance levels.